Publications and Reports

Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23. DM Skowronski, ES Chuang, S Sabaiduc, SE Kaweski, S Kim, JA Dickinson, et al. Euro Surveill. 2023;28(5):

Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada. S Kim, ES Chuang, S Sabaiduc, R Olsha, SE Kaweski, N Zelyas, et al. Euro Surveill. 2022;27(38):

Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010-2011 to 2016-2017. DM Skowronski, M Zou, Q Clarke, C Chambers, JA Dickinson, S Sabaiduc, et al. Clin Infect Dis. 2020;71(16): 2285-2288.

Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada. DM Skowronski, S Leir, S Sabaiduc, C Chambers, M Zou, C Rose, et al. J Infect Dis. 2020;225(8): 1387-1398.

Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020. DM Skowronski, M Zou, S Sabaiduc, M Murti, R Olsha, JA Dickinson, et al. Euro Surveill. 2020;25(7):

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019. DM Skowronski, S Leir, S Sabaiduc, M Murti, JA Dickinson, R Olsha, et al. Euro Surveill. 2019;24(4):

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV). DM Skowronski, S Sabaiduc, S Leir, C Rose, M Zou, M Murti, et al. Euro Surveill. 2019;24(46):

Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010-2011 to 2017-2018. DM Skowronski, C Chambers, G De Serres, S Sabaiduc, AL Winter, JA Dickinson, et al. Clin Infect Dis. 2019;68(10): 1754-1757.

Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ‎possible cohort effect following the 2009 influenza pandemic. DM Skowronski, S Leir, G De Serres, M Murti, JA Dickinson, et al. Euro Surveill. 2019;24(15):pii=1900104.

Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018.  DM Skowronski, C Chambers, G De Serres, S Sabaiduc S, AL Winter AL, JA Dickinson, et al Clin infect Dis. 2019 May 15; 68(10); 1754-1757. doi:10.1093/cid/ciy876.

Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness? C Chambers, DM Skowronski, C Rose,  G De Serres, AL Winter, JA Dickinson, et al. Open forum Infect Dis. 2018 sep; 5(9):ofy211 doi: 10.1093/ofid/ofy211.

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018. DM Skowronski, C Catharine, G De Serres, JA Dickinson, AL Winter, et al. Eurosurveillance. 2018;23(5):pii=18-00035.

Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015–2016 Season in Canada. DM Skowronski, C Chambers, S Sabaiduc, G De Serres, AL Winter, JA Dickinson, et al. JID 2017:216.

Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010–2011 to 2015–2016, Canada DM Skowronski, C Chambers, G De Serres, S Sabaiduc, AL Winter, JA Dickinson, et al. JID 2017:216: 679- 702.

Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada’s Sentinel Physician Surveillance Network, January 2015. DM Skowronski, C Chambers, S Sabaiduc, G De Serres, JA Dickinson, AL Winter , SJ Drews etr al. Euro Surveill. 2015;20(4):pii=21022.

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. DM Skowronski, NZ Janjua , G De Serres , S Sabaiduc , A Eshaghi, JA Dickinson et al. PLoS One. 2014; 9(3): e92153.  doi: 10.1371/journal.pone.0092153.

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019. Skowronski Danuta M, Leir Siobhan, Sabaiduc Suzana, Murti Michelle, Dickinson James A, Olsha Romy, Gubbay Jonathan B, Croxen Matthew A,Charest Hugues, Chan Tracy, Bastien Nathalie, Li Yan, Krajden Mel, De Serres Gaston. Euro Surveill. 2019;24(4):pii=1900055. https://doi.org/10.2807/1560-7917.ES.2019.24.4.1900055

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. Skowronski DM, Chambers C, Sabaiduc S, Dickinson JA, Winter AL, De Serres G, Drews SJ, Jassem A, Gubbay JB, Charest H, Balshaw R, Bastien N, Li Y, Krajden M. Euro Surveill. 2017 Feb 9;22(6): pii=30460. doi: 10.2807/1560-7917.ES.2017.22.6.30460.

A Perfect Storm: impact of genomic Variation and Serial vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season. Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Krajden M, Petric M, Bastien N, Li Y, Smith DJ. J Infect Dis. 2017 Feb 9; 2015-99 doi: 10.1093/infdis/jix074. PubMed PMID: 28180277.

Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15. DM SKowronski, C Chambers, S Sabaiduc, G De Serres, AL Winter, JA Dickinson, et al. Clinical Infectious Disease; 2016:63(1).

Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09. C Chambers, DM SKowronski, S Sabaiduc, AL Winter, JA Dickinson, et al. Euro Surveillance; 2016:21(11).

Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses. DM SKowronski, S Sabaiduc, C Chambers, A Eshaghi, J Gubbay, et al. Euro Surveillance; 2016:21(3).

Integrated Sentinel Surveillance Linking Genetic, Antigenic and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.DM SKowronski, C Chambers, S Sabaiduc, G De Serres, AL Winter, JA Dickinson, et al. Journal of Infectious Disease; 2015:212(5).

Systematic community- and hospital-base surveillance for enterovirus-D68 in three Canadian provinces, August to December 2014. DM SKowronski, C Chambers, S Sabaiduc, M Murti, R Gustafson, S Pollock, et al. Eurosurveillance; 2015:20(43).

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.Danuta M Skowronski, Naveed Z Janjua, Suzana Sabaiduc, Gaston De Serres, Anne-Luise Winter, Jonathan B Gubbay,James A Dickinson, et al.  Journal of Infectious Disease; 2014: 210 (1).

Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada's sentinel surveillance network, January 2014. DM SKowronski, C Chambers, S Sabaiduc, G De Serres, JA Dickinson, et al. Eurosurveillance; 2014:19(5):pii=20690.

Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. DM Skowronski, NZ Janjua, G De Serres, JA Dickinson, AL Winter. Eurosurveillance 2013:18(5):pii=20394.

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-12 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. DM Skowronski, NZ Janjua, S Sabaiduc, G De Serres, AL Winter, et al.Journal of Infectious Diseases; 2014: doi:10.1093/infdis/jiu048

A Sentinel Platform to Evaluate Influenza Vaccine Effectiveness and New Variant Circulation, Canada 2010-11 Season. DM Skowronski, NZ Janjua, GDe Serres, AL Winter, JA Dickinson; JL Gardy, J Gubbay, K Fonseca, H Charest; NS Crowcroft; MD Fradet; N Bastien; Y Li; M Krajden; S Sabaiduc; M Petric
Clinical Infectious Diseases 2012; doi: 10.1093/cid/cis431

Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance sys-tem: Cross protection against major and minor variants. NZ Janjua; DM Skowronski; G De Serres, JA Dickinson, et. al. Journal of Infectious Diseases 2012; doi: 10.1093/infdis/jis283

Report: Survey of Alberta family physicians' reactions to the spring and summer phase of pH1N1 (pandemic swine flu) outbreak, 2009. JA Dickinson, G Bani-Adam, S Berzins, E Medd, K Rivera, T Williamson. Click here to view

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. DM Skowronski, NZ Janjua, G De Serres, TS Hottes, JA Dickinson, et al. BMJ 2011;342:c7297.

Association between the 2008-09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring-Summer 2009: Four observational studies from Canada. DM Skowronski, G De Serres, NS Crowcroft, NZ Janjua, N Boulianne, et al. PLOS; 2010: 7(4): 21000258.

Estimates of Influenza Vaccine Effectiveness for 2007-2008 From Canada's Sentinel Surveillance System: Cross-Protection Against Major and Minor Variants. NZ Janjua, DM Skowronski, G De Serres, JA Dickinson, NS Crowcroft, et al. Journal of Infectious Diseases 2012;205:1858-68.

Component-Specific Effectiveness of Trivalent Influenza Vaccine as Monitored Through a Sentinel Surveillance Network in Canada, 2006-2007. DM Skowronski, G De Serres, J Dickinson, M Petric, A Mak, K Fonseca, TL Kwindt, T Chan, N Bastien, H Charest, Y Li. Journal of Infectious Diseases 2009; 199:168-79.